Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid
Journal of Autism and Developmental Disorders - Trang 1-9
Tóm tắt
Children with autism frequently present with complex mental health diagnoses and psychotropic medications are often a component of comprehensive biopsychosocial treatment plans for these conditions. The purpose of this study is to provide rates and patterns of psychotropic medication use, and predictors thereof, in children and youth with autism enrolled in Medicaid across the US. This study examined national Medicaid claims from 2008 to 2016 of all children and youth with autism ages 0–21 years enrolled in Medicaid. Psychotropic medication use was examined across several child and youth characteristics, including age, co-occurring mental health conditions, sex, and race and ethnicity. About half of children and youth with autism enrolled in Medicaid had at least one psychotropic prescription in a year, a number that decreased slightly across the study period due to decreases in the prescription of antipsychotics. As new medications for autism or co-occurring conditions are developed and deployed, and as the understanding of the characteristics of the population of children with autism evolves, studying rates of medication usage helps to understand utilization patterns and differences in access to quality care.
Tài liệu tham khảo
citation_journal_title=Hormone Molecular Biology and Clinical Investigation; citation_title=Cardiometabolic effects of psychotropic medications; citation_author=O Abosi, S Lopes, S Schmitz, JG Fiedorowicz; citation_publication_date=2018; citation_doi=10.1515/hmbci-2017-0065; citation_id=CR1
citation_journal_title=Journal of Autism and Developmental Disorders; citation_title=Psychotropic medication prescribing for neuropsychiatric comorbidities in individuals diagnosed with autism spectrum disorder (ASD) in the UK; citation_author=BH Alfageh, KK Man, FM Besag, TM Alhawassi, IC Wong, R Brauer; citation_volume=50; citation_issue=2; citation_publication_date=2020; citation_pages=625-633; citation_doi=10.1007/s10803-019-04291-8; citation_id=CR2
citation_journal_title=Psychiatric Services; citation_title=Differences in utilization of mental health treatment among children and adolescents with Medicaid or private insurance; citation_author=MM Ali, LJ Sherman, S Lynch, J Teich, R Mutter; citation_volume=70; citation_issue=4; citation_publication_date=2019; citation_pages=329-332; citation_doi=10.1176/appi.ps.201800428; citation_id=CR3
American Academy of Child Adolescent Psychiatry (AACAP). (2015). Recommendations about the use of psychotropic medications for children and adolescents involved in child-serving systems.
https://www.aacap.org/App_Themes/AACAP/docs/clinical_practice_center/systems_of_care/AACAP_Psychotropic_Medication_Recommendations_2015_FINAL.pdf
citation_journal_title=Journal of Intellectual Disabilities; citation_title=A review of the literature relating to psychological interventions and people with intellectual disabilities: Issues for research, policy, education and clinical practice; citation_author=M Brown, H Duff, T Karatzias, D Horsburgh; citation_volume=15; citation_issue=1; citation_publication_date=2011; citation_pages=31-45; citation_doi=10.1177/1744629511401166; citation_id=CR5
citation_journal_title=Autism; citation_title=Does a claims diagnosis of autism mean a true case?; citation_author=JP Burke, A Jain, W Yang, JP Kelly, M Kaiser, L Becker, L Lawer, CJ Newschaffer; citation_volume=18; citation_issue=3; citation_publication_date=2014; citation_pages=321-330; citation_doi=10.1177/1362361312467709; citation_id=CR6
citation_journal_title=Pediatrics; citation_title=Use of psychotropic medication in children and adolescents with autism spectrum disorders; citation_author=DL Coury, E Anagnostou, P Manning-Courtney, A Reynolds, L Cole, R McCoy, A Whitaker, JM Perrin; citation_volume=130; citation_issue=Supplement 2; citation_publication_date=2012; citation_pages=S69-S76; citation_doi=10.1542/peds.2012-0900D; citation_id=CR7
citation_journal_title=Frontiers in Psychiatry; citation_title=Safety and side effects of psychotropic medications; citation_author=R Filippis, M Solerdelcoll, M Shalbafan; citation_publication_date=2023; citation_doi=10.3389/fpsyt.2023.1148158; citation_id=CR8
citation_journal_title=Journal of the American Academy of Child & Adolescent Psychiatry; citation_title=Systematic review and meta-analysis: Efficacy of pharmacological interventions for irritability and emotional dysregulation in autism spectrum disorder and predictors of response; citation_author=GS Pablo, CP Jordá, J Vaquerizo-Serrano, C Moreno, A Cabras, C Arango, P Hernández, J Veenstra-VanderWeele, E Simonoff, P Fusar-Poli; citation_volume=62; citation_issue=2; citation_publication_date=2023; citation_pages=151-168; citation_doi=10.1016/j.jaac.2022.03.033; citation_id=CR9
citation_journal_title=Chronic Diseases in Canada; citation_title=Validity of autism diagnoses using administrative health data; citation_author=L Dodds, A Spencer, S Shea, D Fell, B Armson, A Allen, S Bryson; citation_volume=29; citation_issue=3; citation_publication_date=2009; citation_pages=102; citation_doi=10.24095/hpcdp.29.3.02; citation_id=CR10
citation_journal_title=BMC Public Health; citation_title=Validation of the diagnosis of autism in general practitioner records; citation_author=E Fombonne, L Heavey, L Smeeth, LC Rodrigues, C Cook, PG Smith, L Meng, AJ Hall; citation_volume=4; citation_issue=1; citation_publication_date=2004; citation_pages=1-9; citation_doi=10.1186/1471-2458-4-5; citation_id=CR11
citation_journal_title=Journal of Autism and Developmental Disorders; citation_title=Decades of progress in the psychopharmacology of autism spectrum disorder; citation_author=E Henneberry, M Lamy, KC Dominick, CA Erickson; citation_volume=51; citation_publication_date=2021; citation_pages=4370-4394; citation_doi=10.1007/s10803-021-05237-9; citation_id=CR12
citation_journal_title=Pediatric Drugs; citation_title=A scoping review of medications studied in pediatric polypharmacy research; citation_author=AE Horace, N Golchin, EMP Knight, NV Dawson, X Ma, JA Feinstein, HK Johnson, L Kleinman, PM Bakaki; citation_volume=22; citation_issue=1; citation_publication_date=2020; citation_pages=85-94; citation_doi=10.1007/s40272-019-00372-4; citation_id=CR13
citation_journal_title=Pediatric Annals; citation_title=Diagnosis and management of comorbid anxiety and ADHD in pediatric primary care; citation_author=D Janiczak, M Perez-Reisler, R Ballard; citation_volume=49; citation_issue=10; citation_publication_date=2020; citation_pages=e436-e439; citation_doi=10.3928/19382359-20200922-01; citation_id=CR14
citation_journal_title=Autism; citation_title=Use of psychotropic drugs in patients with autism spectrum disorders: A systematic review; citation_author=K Jobski, J Höfer, F Hoffmann, CJAPS Bachmann; citation_volume=135; citation_issue=1; citation_publication_date=2017; citation_pages=8-28; citation_id=CR15
citation_journal_title=The Journal of Clinical Psychiatry; citation_title=Prevalence and correlates of caregiver-reported mental health conditions in youth with autism spectrum disorder in the United States; citation_author=CM Kerns, JE Rast, PT Shattuck; citation_publication_date=2020; citation_doi=10.4088/JCP.20m13242; citation_id=CR16
citation_journal_title=General Hospital Psychiatry; citation_title=Examining psychotropic medication use among youth in the US by race/ethnicity and psychological impairment; citation_author=B Lê Cook, NJ Carson, EN Kafali, A Valentine, JD Rueda, S Coe-Odess, S Busch; citation_volume=45; citation_publication_date=2017; citation_pages=32-39; citation_doi=10.1016/j.genhosppsych.2016.12.004; citation_id=CR17
citation_journal_title=Pharmacy and Therapeutics; citation_title=Pharmacological therapies for autism spectrum disorder: A review; citation_author=S LeClerc, D Easley; citation_volume=40; citation_issue=6; citation_publication_date=2015; citation_pages=389; citation_id=CR18
citation_journal_title=Journal of Child and Adolescent Psychopharmacology; citation_title=Aberrant behaviors and co-occurring conditions as predictors of psychotropic polypharmacy among children with autism spectrum disorders; citation_author=SL Logan, L Carpenter, RS Leslie, E Garrett-Mayer, KJ Hunt, J Charles, JS Nicholas; citation_volume=25; citation_issue=4; citation_publication_date=2015; citation_pages=323-336; citation_doi=10.1089/cap.2013.0119; citation_id=CR19
citation_journal_title=Journal of Managed Care & Specialty Pharmacy; citation_title=Psychotropic polypharmacy among children and youth receiving Medicaid, 2012–2015; citation_author=WD Lohr, L Creel, Y Feygin, M Stevenson, MJ Smith, J Myers, C Woods, G Liu, DW Davis; citation_volume=24; citation_issue=8; citation_publication_date=2018; citation_pages=736-744; citation_doi=10.18553/jmcp.2018.24.8.736; citation_id=CR20
Lorberg, B., Davico, C., Martsenkovskyi, D., & Vitiello, B. (2019). Principles in using psychotropic medication in children and adolescents. IACAPAP e-Textbook of Child and Adolescent Mental Health (pp. A7). International Association for Child and Adolescent Psychiatry and Allied Professions.
citation_journal_title=Journal of Autism and Developmental Disorders; citation_title=Psychotropic medication use among insured children with autism spectrum disorder; citation_author=JM Madden, MD Lakoma, FL Lynch, D Rusinak, AA Owen-Smith, KJ Coleman, VP Quinn, VM Yau, YX Qian, LA Croen; citation_volume=47; citation_publication_date=2017; citation_pages=144-154; citation_doi=10.1007/s10803-016-2946-7; citation_id=CR22
citation_journal_title=Pediatrics; citation_title=Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders; citation_author=DS Mandell, KH Morales, SC Marcus, AC Stahmer, J Doshi, DE Polsky; citation_volume=121; citation_issue=3; citation_publication_date=2008; citation_doi=10.1542/peds.2007-0984; citation_id=CR23
citation_journal_title=Frontiers in Endocrinology; citation_title=Impact of psychotropic medication effects on obesity and the metabolic syndrome in people with serious mental illness; citation_author=V Mazereel, J Detraux, D Vancampfort, R Winkel, M Hert; citation_volume=11; citation_publication_date=2020; citation_doi=10.3389/fendo.2020.573479; citation_id=CR24
citation_journal_title=Autism; citation_title=Psychopharmacology of autism spectrum disorders: A selective review; citation_author=S Mohiuddin, MJA Ghaziuddin; citation_volume=17; citation_issue=6; citation_publication_date=2013; citation_pages=645-654; citation_doi=10.1177/1362361312453776; citation_id=CR25
citation_journal_title=Trends in Neurosciences; citation_title=The use of language in autism research; citation_author=R Monk, AJ Whitehouse, H Waddington; citation_volume=45; citation_issue=11; citation_publication_date=2022; citation_pages=791-793; citation_doi=10.1016/j.tins.2022.08.009; citation_id=CR26
citation_journal_title=Progress in Neuro-Psychopharmacology and Biological Psychiatry; citation_title=The pediatric psychopharmacology of autism spectrum disorder: A systematic review-Part I: The past and the present; citation_author=AM Persico, A Ricciardello, M Lamberti, L Turriziani, F Cucinotta, C Brogna, B Vitiello, C Arango; citation_volume=110; citation_publication_date=2021; citation_doi=10.1016/j.pnpbp.2021.110326; citation_id=CR27
citation_journal_title=Journal of Applied Research in Intellectual Disabilities; citation_title=Exploring barriers and facilitators in the implementation and use of guideline recommendations on antipsychotic drug prescriptions for people with intellectual disability; citation_author=L Ramerman, PJ Hoekstra, G Kuijper; citation_volume=31; citation_issue=6; citation_publication_date=2018; citation_pages=1062-1070; citation_doi=10.1111/jar.12461; citation_id=CR28
Rast, J., Roux, A., Anderson, K., Croen, L., Kuo, L., Shea, L., & Shattuck, P. (2020). National autism indicators report: Health and health care.
drexel.edu/autismoutcomes/nairhealth
Rast, J., Garfield, T., Roux, A., Anderson, K., Miller, K. K., Hund, L., Tao, S., Kerns, C., Rosenau, K., Hotez, E., Shattuck, P., & Shea, L. (2021). National autism indicators report: Mental health. drexel.edu/autismoutcomes/mentalhealth
citation_journal_title=Autism; citation_title=Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program; citation_author=JR Schubart, F Camacho, D Leslie; citation_volume=18; citation_issue=6; citation_publication_date=2014; citation_pages=631-637; citation_doi=10.1177/1362361313497537; citation_id=CR31
citation_journal_title=World Psychiatry; citation_title=Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: A large scale systematic meta-review of 78 adverse effects; citation_author=M Solmi, M Fornaro, EG Ostinelli, C Zangani, G Croatto, F Monaco, D Krinitski, P Fusar-Poli, CU Correll; citation_volume=19; citation_issue=2; citation_publication_date=2020; citation_pages=214-232; citation_doi=10.1002/wps.20765; citation_id=CR32
citation_journal_title=Pediatrics; citation_title=Psychotropic medication use and polypharmacy in children with autism spectrum disorders; citation_author=D Spencer, J Marshall, B Post, M Kulakodlu, C Newschaffer, T Dennen, F Azocar, A Jain; citation_volume=132; citation_issue=5; citation_publication_date=2013; citation_pages=833; citation_doi=10.1542/peds.2012-3774; citation_id=CR33
citation_journal_title=Journal of Child and Adolescent Psychopharmacology; citation_title=The effects of prior authorization policies on Medicaid-enrolled children’s use of antipsychotic medications: Evidence from two mid-Atlantic states; citation_author=BD Stein, E Leckman-Westin, E Okeke, DM Scharf, M Sorbero, Q Chen, KHB Chor, M Finnerty, JP Wisdom; citation_volume=24; citation_issue=7; citation_publication_date=2014; citation_pages=374-381; citation_doi=10.1089/cap.2014.0008; citation_id=CR34
citation_journal_title=Journal of the American Academy of Child & Adolescent Psychiatry; citation_title=Practice parameter on the use of psychotropic medication in children and adolescents; citation_author=J Walkup; citation_volume=48; citation_issue=9; citation_publication_date=2009; citation_pages=961-973; citation_doi=10.1097/CHI.0b013e3181ae0a08; citation_id=CR35